Conference Menu
Overview
Day 1
Day 2
Register
PDF Download
Hotel & Travel Info
Sponsor
Press Pass
Request Brochure
Stay on for the Third Annual
Portfolio Management Executive Forum
November 18-19, 2008
Philadelphia, PA
The First 25 Registrants Will Receive a Free Copy of:
Anand Sanwal
Investment Optimization
and Strategic Business
Analysis, at American Express
Keynote Presenter at this Year’s Event.
|
Supporting Association
Corporate Sponsors
Lead Sponsoring Publications:
Media Partners:
|
|
FEATURED PRESENTATIONS:
Utilizing Corporate Portfolio Management to Stop Investile Dysfunction
 Anand Sanwal, Managing Director, Brilliont; Former VP, Investment Optimization & Strategic Business Analysis, American Express
|
Integrating Value into the Portfolio Decision-Making Framework
 Jean Lee, Director, WWD Portfolio Management, Pfizer -Co developed with Lori S. Shafne, Vice President, Portfolio and Project Management, Pfizer
|
Evolution of Resource Management Capability at a Large Biotechnology Company
 Matthew Riddell, M.B.A., Associate Director, Research & Development Planning & Operations, Program & Alliance Management, Biogen Idec
|
Pearls of Wisdom in Building Strong Partnerships for a Robust and Scalable R&D Organization
 Eric Morfin, Senior Director, Project Management, Aradigm; Chair, PMI Pharmaceutical SIG
|
Valuing a Diverse Portfolio: The Move from Selling Medicines to Promoting Health
 Marilyn Metcalf, Ph.D., Director, Quantitative and Decision Sciences, GlaxoSmithKline
|
Cost-Risk-Value Optimization – Enabling Drug Developers to “Do the right thing”
 Stephen A. Williams, Ph.D., Partner, Decisionability LLC; Former Vice President and Worldwide Head of Clinical Technology, Pfizer
|
Strategic Resource Management: Go Beyond Fancy Charts and Truly Impact Strategic Business Decisions
 Maureen Martini, Senior Project Manager, Global Strategic Planning and Program Management, Shire Pharmaceuticals
|
Successful Portfolio Management within Discovery at AstraZeneca
 Richard Lawson, Ph.D., Global Head of Discovery Decision Support, Discovery Strategy and Performance, AstraZeneca Pharmaceuticals, Inc.
|
 Christopher Beck, Vice President, Global Strategic Planning and Program Management, Shire Pharmaceuticals
|
Aligning Strategic Capacity Management with Business Development in Healthcare Product Safety
 Colin Cornhill, Senior Director, Strategic Planning, BRM, Johnson & Johnson Pharmaceutical R&D
|
Developing Successful Project Leaders
 Chad Nikel, Director of Business Development, Integrated Project Management
|
|
Distinguished Faculty:
- Murray Aitken, Senior Vice President, Healthcare Insight, IMS Health Inc.
- Greg Bayer, Executive Director, Global Development Planning & Resource Management, Bristol Myers-Squibb
- Richard M. Bayney, Ph.D., President & Founder, Project & Portfolio Value Creation, and Faculty, University of Pennsylvania
- Sabine Bernotat-Danielowski, Ph.D., M.B.A, Executive Director, Decision Analysis, Daiichi Sankyo
- Ashraf Hanna, Ph.D., M.D., Vice President, Alliance Management & Portfolio Planning, Genentech Inc.
- Peter Heinrich, Ph.D., CEO, Portfolio DecisionWare, Inc.
- Jeff Hewitt, Senior Principal, SDG life sciences, a unit of IMS
- Jennifer Hirsch, Associate Director, R&D Operations, Johnson & Johnson Pharmaceutical R&D
- J. Mark Horn, Director, Finance and R&D Portfolio Management, Wyeth Consumer Healthcare
- John I. Howell III, President, Portfolio Decisions, Inc.
- Matthew Kiernan, Partner, Pharmica Consulting
- Grant Morgan, Ph.D., PMP, Leader of R&D Metrics and Capacity Management, Senior Global Project Manager, Allergan, Inc.
- Chad Nikel, Director of Business Development, Integrated Project Management
- Paul Ranky, Ph.D., Professor, Department of Industrial and Management Systems Engineering and IT, New Jersey Institute of Technology
- James F. Resch, Ph.D., Director, Strategic Intelligence, Discovery Strategy and Performance, AstraZeneca Pharmaceuticals, Inc.
- Otto Ritter, Ph.D., Associate Director, Global Discovery Information, AstraZeneca Pharmaceuticals LP
- Michael Shulman, Editor/Analyst, ChangeWave
- Daniel Smith, Vice President, Enrich Consulting
- Lillian Warren, Chief Operating Officer, Portfolio Decisions, Inc.
- Mark Yuzuk, Associate Director, R&D Ops Informatics, Bristol Myers-Squibb
- Yan Zhang, Ph.D., Head, Pipeline and Portfolio Planning, Genentech Inc.
|
|
|